Furthermore, CRP blood levels have been associated with reduced performance in the TMT in several patient groups experiencing ongoing peripheral inflammatory activity, such as those with peripheral arterial disease [49] and brain cancer [50] and aging populations [51]. This evidence concerns the gene CRP and peripheral arterial disease.